A study by the Institute for Bioengineering of Catalonia (IBEC) and Northwestern University (USA), published Wednesday in the Journal of the American Chemical Society, reported on a novel nanotherapy to combat neurodegenerative diseases such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS).